See how we rate banking products to write unbiased product reviews. Massachusetts residents will want to prioritize banks and credit unions that operate in Massachusetts. We reviewed several ...
Massachusetts voters went to the polls on Sept. 3 to cast their ballots in a host of local and state primary elections. races. Here are the key results, and a look ahead to the general election ...
(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...
WASHINGTON (AP) — Massachusetts voters will cast ballots for president, Congress and the state Legislature in the Nov. 5 general election, as Democrats in the commonwealth look to continue their ...
Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...
Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...
Whenever you vote, don’t forget all the races further down the ballot. Right now, Massachusetts is a one-party state. How’s that one working out for you? Pretty damn good, if you’re a ...
Sanofi expects a low single-digit decline in flu shot sales due to the soft vaccination rate. Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company ...
Agomab Therapeutics is benefiting from Sanofi’s push to become an immunology powerhouse.
(Reuters) - French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than-anticipated start of the vaccination season.
Leerink Partners analyst David Risinger in a Friday note to investors said Sanofi expects Q4 Beyfortus sales similar to Q3. Sanofi released its third-quarter earnings report on Friday, beating ...